Macro- and micro-influencers of antimicrobial costs…What do stewardship programs need to know?
- PMID: 40026754
- PMCID: PMC11869052
- DOI: 10.1017/ash.2025.38
Macro- and micro-influencers of antimicrobial costs…What do stewardship programs need to know?
Abstract
The high cost of antimicrobials presents critical challenges for healthcare providers managing infections amidst the growing threat of antimicrobial resistance (AMR). High costs hinder access to necessary treatments, disproportionately affecting disadvantaged populations and exacerbating health disparities. High drug prices necessitate the use of less effective or more toxic alternatives, leading to suboptimal outcomes and prolonged hospitalizations. This, in turn, increases healthcare costs and undermines efforts to combat AMR. Equitable policies, national formularies, and cost caps for essential antimicrobials can ensure universal access to life-saving treatments and enable antimicrobial stewardship programs to ensure the best possible outcomes.
© The Author(s) 2025.
Conflict of interest statement
SK has no conflicts of interest to disclose. SA has no conflicts of interest to disclose. KMS has no conflicts of interest to disclose. MH has served as an UpToDate contributor. JLW has served on an advisory board for Innoviva.
Figures
References
-
- Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016;316:858–871. - PubMed
-
- Lopes L, Stokes M, 2022. Public Opinion on Prescription Drugs and Their Prices. Kaiser Family Foundation. Published October 20, 2022. Accessed December 7, 2024. https://www.kff.org/health-costs/poll-finding/public-opinion-on-prescrip...
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous